
Greenberg Traurig Nabs Eight Nominations for 2026 LMG Life Sciences Awards
Four individual shareholders and the firm itself have secured positions on the 2026 LMG Life Sciences Americas Awards shortlist. The nominations, spanning litigation, patent strategy, and corporate transactions, highlight the firm’s reach across the pharmaceutical and medical technology sectors ahead of the September ceremony in New York City.
























